Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled study.
Zoe Menczel SchrireCraig L PhillipsShantel L DuffyNathaniel S MarshallLoren MowszowskiHaley M La MonicaChristopher J GordonJulia L ChapmanBandana SainiSimon J G LewisSharon L NaismithRonald R GrunsteinCamilla M HoyosPublished in: BMJ open (2021)
V.8 15 October 2020.
Keyphrases
- mild cognitive impairment
- double blind
- oxidative stress
- cognitive decline
- clinical trial
- placebo controlled
- open label
- resting state
- randomized controlled trial
- white matter
- study protocol
- sleep quality
- physical activity
- dna damage
- ischemia reperfusion injury
- diabetic rats
- functional connectivity
- cerebral ischemia
- induced apoptosis